The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Cancer treatment and survivorship statistics, 2025
Open accessAbstract
The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using data from the Surveillance, Epidemiology, and End Results cancer registries, the Centers for Disease Control and Prevention's National Center for Health Statistics, and the United States Census Bureau. In addition, cancer treatment patterns are presented from the National Cancer Database along with a brief overview of treatment‐related side effects. As of January 1, 2025, about 18.6 million people were living in the United States with a history of cancer, and this number is projected to exceed 22 million by 2035. The three most prevalent cancers are prostate (3,552,460), melanoma of the skin (816,580), and colorectum (729,550) among males and breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) among females. About one half (51%) of survivors were diagnosed within the past 10 years, and nearly four fifths (79%) were aged 60 years and older. Racial differences in treatment in 2021 were common across disease stage; for example, Black people with stage I‐II lung cancer were less likely to undergo surgery than their White counterparts (47% vs. 52%). Larger disparities exist for rectal cancer, for which 39% of Black people with stage I disease undergo proctectomy or proctocolectomy compared to 64% of their White counterparts. Targeted, multi‐level efforts to expand access to high‐quality care and survivorship resources are vital to reducing disparities and advancing support for all survivors of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,403
Self-citationImmune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849
Colorectal cancer statistics, 2023
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21772 · Cited by 3,733
Self-citationCancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Self-citationFirst-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer
Horn, L., Mansfield, A. S., Szczęsna, A., Havel, L., Krzakowski, M., Hochmair, M. J., Huemer, F., Losonczy, G., Johnson, M. L., Nishio, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1809064 · Cited by 3,586
Döhner, H., Weisdorf, D. J., & Bloomfield, C. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1406184 · Cited by 3,306
Pembrolizumab for Early Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Pusztai, L., McArthur, H., Kümmel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910549 · Cited by 3,270
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,060
Self-citationLutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Sartor, O., de Bono, J., Chi, K. N., Fizazi, K., Herrmann, K., Rahbar, K., Tagawa, S. T., Nordquist, L. T., Vaishampayan, N., El-Haddad, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107322 · Cited by 2,864
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203690 · Cited by 2,664
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Biller, L. H., & Schrag, D. (2021) · JAMA · doi:10.1001/jama.2021.0106 · Cited by 2,604
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
Olaparib for Metastatic Castration-Resistant Prostate Cancer
de Bono, J., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K. N., Sartor, O., Agarwal, N., Olmos, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911440 · Cited by 2,323
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Martins, F., Sofiya, L., Sykiotis, G. P., Lamine, F., Maillard, M., Fraga, M., Shabafrouz, K., Ribi, C., Cairoli, A., Guex-Crosier, Y., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0218-0 · Cited by 2,314
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Fizazi, K., Tran, N., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B. Y., Özgüroğlu, M., Ye, D., Feyerabend, S., Protheroe, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704174 · Cited by 2,308
Increasing trends in regional heatwaves
Perkins-Kirkpatrick, S. E., & Lewis, S. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16970-7 · Cited by 1,912
Abiraterone for prostate cancer not previously treated with hormone therapy
James, N. D., de Bono, J. S., Spears, M. R., Clarke, N. W., Mason, M. D., Dearnaley, D. P., Ritchie, A. W. S., Amos, C. L., Gilson, C., Jones, R. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702900 · Cited by 1,801
International incidence of childhood cancer, 2001–10: a population-based registry study
Steliarova-Foucher, E., Colombet, M., Ries, L. A. G., Moreno, F., Dolya, A., Bray, F., Hesseling, P., Shin, H. Y., Stiller, C. A., Bouzbid, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30186-9 · Cited by 1,757
Self-citationAdjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer
Tutt, A. N. J., Garber, J. E., Kaufman, B., Viale, G., Fumagalli, D., Rastogi, P., Gelber, R. D., de Azambuja, E., Fielding, A., Balmaña, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105215 · Cited by 1,729
Self-citationLenis, A. T., Lec, P. M., Chamie, K., & MSHS, M. (2020) · JAMA · doi:10.1001/jama.2020.17598 · Cited by 1,728
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Bardia, A., Hurvitz, S. A., Tolaney, S. M., Loirat, D., Punie, K., Oliveira, M., Brufsky, A., Sardesai, S. D., Kalinsky, K., Zelnak, A. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028485 · Cited by 1,711
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
How Structural Racism Works — Racist Policies as a Root Cause of U.S. Racial Health Inequities
Bailey, Z. D., Feldman, J. M., & Bassett, M. T. (2021) · New England Journal of Medicine · doi:10.1056/nejmms2025396 · Cited by 1,598
International Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update
Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., Wallace, W. H., Wang, E. T., & Loren, A. W. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.1914 · Cited by 1,486
American Joint Committee on Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88441-7 · Cited by 1,328
Armenian, S. H., Lacchetti, C., Barac, A., Carver, J., Constine, L. S., Denduluri, N., Dent, S., Douglas, P. S., Durand, J.-B., Ewer, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5400 · Cited by 1,290
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., Grünwald, V., Gillessen, S., & Horwich, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz056 · Cited by 1,151
Duration of adjuvant chemotherapy for stage III colon cancer
Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713709 · Cited by 1,092
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Self-citationThe Epidemiology of Renal Cell Carcinoma
Ljungberg, B., Campbell, S. C., Cho, H. Y., Jacqmin, D., Lee, J. E., Weikert, S., & Kiemeney, L. A. (2011) · European Urology · doi:10.1016/j.eururo.2011.06.049 · Cited by 999
Biologic and Clinical Perspectives on Thyroid Cancer
Fagin, J. A., & Wells, S. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1501993 · Cited by 990
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mirza, M. R., Chase, D. M., Slomovitz, B. M., dePont Christensen, R., Novák, Z., Black, D., Gilbert, L., Sharma, S., Valabrega, G., Landrum, L. M., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2216334 · Cited by 862
Giaquinto, A. N., Sung, H., Newman, L. A., Freedman, R. A., Smith, R. A., Star, J., Jemal, A., & Siegel, R. L. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21863 · Cited by 799
Self-citationSurvival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
Hussain, M., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K. N., Sartor, O., Agarwal, N., Olmos, D., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022485 · Cited by 792
Modi, S., Park, H., Murthy, R. K., Iwata, H., Tamura, K., Tsurutani, J., Moreno-Aspitia, A., Doi, T., Sagara, Y., Redfern, C., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02318 · Cited by 787
Acute myeloid leukemia: current progress and future directions
Kantarjian, H., Kadia, T., DiNardo, C., Daver, N., Borthakur, G., Jabbour, E., Garcia-Manero, G., Konopleva, M., & Ravandi, F. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00425-3 · Cited by 776
Adapt to more wildfire in western North American forests as climate changes
Schoennagel, T., Balch, J. K., Brenkert-Smith, H., Dennison, P. E., Harvey, B. J., Krawchuk, M. A., Mietkiewicz, N., Morgan, P., Moritz, M. A., Rasker, R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617464114 · Cited by 774
Malard, F., & Mohty, M. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33018-1 · Cited by 773
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Eskander, R. N., Sill, M. W., Beffa, L., Moore, R. G., Hope, J. M., Musa, F. B., Mannel, R., Shahin, M. S., Cantuaria, G. H., Girda, E., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2302312 · Cited by 758
Long, G. V., Swetter, S. M., Menzies, A. M., Gershenwald, J. E., & Scolyer, R. A. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00821-8 · Cited by 746
American Cancer Society nutrition and physical activity guideline for cancer survivors
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21719 · Cited by 741
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Armstrong, G. T., Oeffinger, K. C., Chen, Y., Kawashima, T., Yasui, Y., Leisenring, W., Stovall, M., Chow, E. J., Sklar, C. A., Mulrooney, D. A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3205 · Cited by 734
Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0944 · Cited by 730
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Oaknin, A., Bosse, T. J., Creutzberg, C. L., Giornelli, G., Harter, P., Joly, F., Lorusso, D., Marth, C., Makker, V., Mirza, M. R., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.05.009 · Cited by 652
Patt, D., Gordan, L., Diaz, M., Okon, T., Grady, L., Harmison, M., Markward, N., Sullivan, M., Peng, J., & Zhou, A. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00134 · Cited by 646
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
Schaeffer, E. M., Srinivas, S., Adra, N., An, Y., Barocas, D., Bitting, R., Bryce, A., Chapin, B., Cheng, H. H., D’Amico, A. V., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0050 · Cited by 596
Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00020-x · Cited by 590
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
Armstrong, G. T., Chen, Y., Yasui, Y., Leisenring, W., Gibson, T. M., Mertens, A. C., Stovall, M., Oeffinger, K. C., Bhatia, S., Krull, K. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510795 · Cited by 568
Balar, A. V., Kamat, A. M., Kulkarni, G. S., Uchio, E. M., Boormans, J. L., Roumiguié, M., Krieger, L. E. M., Singer, E. A., Bajorin, D. F., Grivas, P., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00147-9 · Cited by 565
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
Blank, C. U., Lucas, M. W., Scolyer, R. A., van de Wiel, B. A., Menzies, A. M., Lopez-Yurda, M., Hoeijmakers, L. L., Saw, R. P. M., Lijnsvelt, J. M., Maher, N. G., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2402604 · Cited by 542
Ellis, L., Canchola, A. J., Spiegel, D., Ladabaum, U., Haile, R., & Gomez, S. L. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.2049 · Cited by 536
Shyam Sunder, S., Sharma, U. C., & Pokharel, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01469-6 · Cited by 508
Advances in diagnosis and treatment of bladder cancer
Lopez-Beltran, A., Cookson, M. S., Guercio, B. J., & Cheng, L. (2024) · BMJ · doi:10.1136/bmj-2023-076743 · Cited by 496
Stock, W., Luger, S. M., Advani, A. S., Yin, J., Harvey, R. C., Mullighan, C. G., Willman, C. L., Fulton, N., Laumann, K. M., Malnassy, G., et al. (2019) · Blood · doi:10.1182/blood-2018-10-881961 · Cited by 488
Barr, R. D., Ferrari, A., Ries, L., Whelan, J., & Bleyer, W. A. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.4689 · Cited by 451
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Shimony, S., Stahl, M., & Stone, R. M. (2023) · American Journal of Hematology · doi:10.1002/ajh.26822 · Cited by 448
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Compérat, E., Amin, M. B., Cathomas, R., Choudhury, A., De Santis, M., Kamat, A., Stenzl, A., Thoeny, H. C., & Witjes, J. A. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01188-6 · Cited by 435
Weaver, K. E., Forsythe, L. P., Reeve, B. B., Alfano, C. M., Rodriguez, J. L., Sabatino, S. A., Hawkins, N. A., & Rowland, J. H. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0740 · Cited by 398
Mallin, K., Browner, A., Palis, B., Gay, G., McCabe, R., Nogueira, L., Yabroff, R., Shulman, L., Facktor, M., Winchester, D. P., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07213-1 · Cited by 396
Self-citationDietz, J. R., Moran, M. S., Isakoff, S. J., Kurtzman, S. H., Willey, S. C., Burstein, H. J., Bleicher, R. J., Lyons, J. A., Sarantou, T., Baron, P. L., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05644-z · Cited by 393
Renal Cell Carcinoma: A Review
Rose, T. L., & Kim, W. Y. (2024) · JAMA · doi:10.1001/jama.2024.12848 · Cited by 374
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Baxter, N. N., Kennedy, E. B., Bergsland, E., Berlin, J., George, T. J., Gill, S., Gold, P. J., Hantel, A., Jones, L., Lieu, C., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02538 · Cited by 367
Lee, R. K., Abol‐Enein, H., Artibani, W., Bochner, B., Dalbagni, G., Daneshmand, S., Fradet, Y., Hautmann, R. E., Lee, C. T., Lerner, S. P., et al. (2014) · BJU International · doi:10.1111/bju.12121 · Cited by 360
Carter, J., Lacchetti, C., Andersen, B. L., Barton, D. L., Bolte, S., Damast, S., Diefenbach, M. A., DuHamel, K., Florendo, J., Ganz, P. A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.8995 · Cited by 359
Self-citationCAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review
Brudno, J. N., Maus, M. V., & Hinrichs, C. S. (2024) · JAMA · doi:10.1001/jama.2024.19462 · Cited by 359
Raychaudhuri, R., Lin, D. W., & Montgomery, R. B. (2025) · JAMA · doi:10.1001/jama.2025.0228 · Cited by 355
Care for the cancer caregiver: A systematic review
Applebaum, A. J., & Breitbart, W. (2013) · Palliative and Supportive Care · doi:10.1017/s1478951512000594 · Cited by 352
Barton, S. E., Najita, J. S., Ginsburg, E. S., Leisenring, W. M., Stovall, M., Weathers, R. E., Sklar, C. A., Robison, L. L., & Diller, L. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70251-1 · Cited by 337
Wang, L., Guyatt, G. H., Kennedy, S. A., Romerosa, B., Kwon, H. Y., Kaushal, A., Chang, Y., Craigie, S., de Almeida, C. P. B., Couban, R. J., et al. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151276 · Cited by 334
DeAngelo, D. J., Stevenson, K. E., Dahlberg, S. E., Silverman, L. B., Couban, S., Supko, J. G., Amrein, P. C., Ballen, K. K., Seftel, M. D., Turner, A. R., et al. (2015) · Leukemia · doi:10.1038/leu.2014.229 · Cited by 330
Skin biopsy rates and incidence of melanoma: population based ecological study
Welch, H. G., Woloshin, S., & Schwartz, L. M. (2005) · BMJ · doi:10.1136/bmj.38516.649537.e0 · Cited by 330
Young Adult Oncology: The Patients and Their Survival Challenges
Bleyer, A. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.4.242 · Cited by 324
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Dai, H., Wang, Y., Lu, X., & Han, W. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv439 · Cited by 299
Clarke, M. A., Devesa, S. S., Harvey, S. V., & Wentzensen, N. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00151 · Cited by 299
Franzoi, M. A., Agostinetto, E., Perachino, M., Del Mastro, L., de Azambuja, E., Vaz-Luis, I., Partridge, A. H., & Lambertini, M. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30666-5 · Cited by 290
Prevalence of cancer survivors in the United States
Tonorezos, E., Devasia, T., Mariotto, A. B., Mollica, M. A., Gallicchio, L., Green, P., Doose, M., Brick, R., Streck, B., Reed, C., et al. (2024) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djae135 · Cited by 290
Self-citationAnalysis of Breast Cancer Mortality in the US—1975 to 2019
Caswell-Jin, J. L., Sun, L. P., Munoz, D., Lu, Y., Li, Y., Huang, H., Hampton, J. M., Song, J., Jayasekera, J., Schechter, C., et al. (2024) · JAMA · doi:10.1001/jama.2023.25881 · Cited by 284
Early Specialty Palliative Care — Translating Data in Oncology into Practice
Parikh, R. B., Kirch, R. A., Smith, T. J., & Temel, J. S. (2013) · New England Journal of Medicine · doi:10.1056/nejmsb1305469 · Cited by 279
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
Mithoowani, H., & Febbraro, M. (2022) · Current Oncology · doi:10.3390/curroncol29030150 · Cited by 259
An overview of infectious complications after allogeneic hematopoietic stem cell transplantation
Sahin, U., Toprak, S. K., Atilla, P. A., Atilla, E., & Demirer, T. (2016) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2016.05.006 · Cited by 252
Acute promyelocytic leukemia current treatment algorithms
Yilmaz, M., Kantarjian, H., & Ravandi, F. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00514-3 · Cited by 238
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review
Shadman, M. (2023) · JAMA · doi:10.1001/jama.2023.1946 · Cited by 237
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States
Gallicchio, L., Devasia, T. P., Tonorezos, E., Mollica, M. A., & Mariotto, A. (2022) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djac158 · Cited by 210
Self-citationYabroff, K. R., Mariotto, A., Tangka, F., Zhao, J., Islami, F., Sung, H., Sherman, R. L., Henley, S. J., Jemal, A., & Ward, E. M. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab192 · Cited by 208
Self-citationChronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring
Jabbour, E., & Kantarjian, H. (2024) · American Journal of Hematology · doi:10.1002/ajh.27443 · Cited by 207
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Hamilton, M. P., Sugio, T., Noordenbos, T., Shi, S., Bulterys, P. L., Liu, C. L., Kang, X., Olsen, M. N., Good, Z., Dahiya, S., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2401361 · Cited by 205
McLaughlin, S. A., Brunelle, C. L., & Taghian, A. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02896 · Cited by 204
Clement, S. C., Peeters, R. P., Ronckers, C. M., Links, T. P., van den Heuvel-Eibrink, M. M., Nieveen van Dijkum, E. J. M., van Rijn, R. R., van der Pal, H. J. H., Neggers, S. J., Kremer, L. C. M., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.09.001 · Cited by 197
Wasilewski-Masker, K., Seidel, K. D., Leisenring, W., Mertens, A. C., Shnorhavorian, M., Ritenour, C. W., Stovall, M., Green, D. M., Sklar, C. A., Armstrong, G. T., et al. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0354-6 · Cited by 190
Gemtuzumab ozogamicin for acute myeloid leukemia
Appelbaum, F. R., & Bernstein, I. D. (2017) · Blood · doi:10.1182/blood-2017-09-797712 · Cited by 184
Boughey, J. C., Attai, D. J., Chen, S. L., Cody, H. S., Dietz, J. R., Feldman, S. M., Greenberg, C. C., Kass, R. B., Landercasper, J., Lemaine, V., et al. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5443-5 · Cited by 181
Jemal, A., Robbins, A. S., Lin, C. C., Flanders, W. D., DeSantis, C. E., Ward, E. M., & Freedman, R. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7932 · Cited by 181
Self-citationPrevalence of pain in patients with breast cancer post-treatment: A systematic review
Wang, K., Yee, C., Tam, S., Drost, L., Chan, S., Zaki, P., Rico, V., Ariello, K., Dasios, M., Lam, H., et al. (2018) · The Breast · doi:10.1016/j.breast.2018.08.105 · Cited by 176
Rosenberg, S. M., Dominici, L. S., Gelber, S., Poorvu, P. D., Ruddy, K. J., Wong, J. S., Tamimi, R. M., Schapira, L., Come, S., Peppercorn, J. M., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.3325 · Cited by 176
Developing Interventions for Cancer-Related Cognitive Dysfunction in Childhood Cancer Survivors
Castellino, S. M., Ullrich, N. J., Whelen, M. J., & Lange, B. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju186 · Cited by 175
Medical financial hardship among cancer survivors in the United States
Zheng, Z., Jemal, A., Han, X., Guy, G. P., Li, C., Davidoff, A. J., Banegas, M. P., Ekwueme, D. U., & Yabroff, K. R. (2019) · Cancer · doi:10.1002/cncr.31913 · Cited by 172
Self-citationAmerican Cancer Society’s report on the status of cancer disparities in the United States, 2023
Islami, F., Bispo, J. B., Lee, H., Wiese, D., Yabroff, K. R., Bandi, P., Sloan, K., Patel, A. V., Daniels, E. C., Kamal, A. H., et al. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21812 · Cited by 171
Self-citationA National Profile Of End-Of-Life Caregiving In The United States
Ornstein, K. A., Kelley, A. S., Bollens-Lund, E., & Wolff, J. L. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0134 · Cited by 167
Han, C. J., Yang, G. S., & Syrjala, K. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000785 · Cited by 165
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma
Kannarkatt, J., Joseph, J., Kurniali, P. C., Al-Janadi, A., & Hrinczenko, B. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.017210 · Cited by 164
Elsallab, M., Ellithi, M., Lunning, M. A., D'Angelo, C. R., Ma, J., Perales, M., Frigault, M. J., & Maus, M. V. (2024) · Blood · doi:10.1182/blood.2024024166 · Cited by 157
Pasqual, E., Schonfeld, S. J., Morton, L. M., Villoing, D., Lee, C., de González, A. B., & Kitahara, C. M. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01841 · Cited by 154
Bates, J. E., Howell, R. M., Liu, Q., Yasui, Y., Mulrooney, D. A., Dhakal, S., Smith, S. A., Leisenring, W. M., Indelicato, D. J., Gibson, T. M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01764 · Cited by 152
Safety of Ovarian Preservation in Premenopausal Women With Endometrial Cancer
Wright, J. D., Buck, A. M., Shah, M. M., Burke, W. M., Schiff, P. B., & Herzog, T. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8150 · Cited by 151
Tobacco Smoking and Risk of Second Primary Lung Cancer
Aredo, J. V., Luo, S. J., Gardner, R. M., Sanyal, N., Choi, E., Hickey, T. P., Riley, T. L., Huang, W., Kurian, A. W., Leung, A. N. C., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.02.024 · Cited by 151
Transurethral resection of bladder tumour (TURBT)
Kim, L. H. C., & Patel, M. I. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.09.38 · Cited by 149
A systematic review of psychosocial interventions to improve cancer caregiver quality of life
Waldron, E. A., Janke, E. A., Bechtel, C. F., Ramirez, M., & Cohen, A. (2013) · Psycho-Oncology · doi:10.1002/pon.3118 · Cited by 147
CHESS improves cancer caregivers’ burden and mood: Results of an eHealth RCT.
DuBenske, L. L., Gustafson, D. H., Namkoong, K., Hawkins, R. P., Atwood, A. K., Brown, R., Chih, M., Mctavish, F. M., Carmack, C. L., Buss, M. K., et al. (2013) · Health Psychology · doi:10.1037/a0034216 · Cited by 145
Chan, R. J., Crichton, M., Crawford-Williams, F., Agbejule, O. A., Yu, K., Hart, N. H., de Abreu Alves, F., Ashbury, F. D., Eng, L., Fitch, M., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.001 · Cited by 144
Bowen, D. J., Alfano, C. M., McGregor, B. A., Kuniyuki, A. A., Bernstein, L., Meeske, K., Baumgartner, K. B., Fetherolf, J., Reeve, B. B., Smith, A. W., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9479-2 · Cited by 143
Self-citationSilkenstedt, E., Salles, G. A., Campo, E., & Dreyling, M. H. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02705-8 · Cited by 139
Attard, G., Murphy, L. R., Clarke, N. W., Sachdeva, A., Jones, C. H., Hoyle, A. P., Cross, W. R., Jones, R. J., Parker, C. C., Gillessen, S., et al. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00148-1 · Cited by 135
Oncocardiology—Past, Present, and Future
Yeh, E. T. H., & Chang, H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2132 · Cited by 134
Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer
Sineshaw, H. M., Ng, K., Flanders, W. D., Brawley, O. W., & Jemal, A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.11.005 · Cited by 128
Self-citationPostdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality
Sheikh, M., Феликсовна, М. А., Shangina, O., Brennan, P., & Zaridze, D. G. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0252 · Cited by 126
Zhang, D. “., Shi, L., Han, X., Li, Y., Jalajel, N. A., Patel, S., Chen, Z., Chen, L., Wen, M., Li, H., et al. (2021) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x211051677 · Cited by 125
Estimation and projections of cancer prevalence from cancer registry data
Verdecchia, A., Angelis, G. D., & Capocaccia, R. (2002) · Statistics in Medicine · doi:10.1002/sim.1304 · Cited by 119
Sonbol, M. B., Mountjoy, L. J., Firwana, B., Liu, A. J., Almader‐Douglas, D., Mody, K., Hubbard, J. M., Borad, M. J., Ahn, D. H., Murad, M. H., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.4489 · Cited by 119
Salem, M. E., El-Refai, S. M., Sha, W., Puccini, A., Grothey, A., George, T. J., Hwang, J. J., O’Neil, B. H., Barrett, A. S., Kadakia, K. C., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00245 · Cited by 119
Hodgkin lymphoma: 2025 update on diagnosis, risk‐stratification, and management
Ansell, S. M. (2024) · American Journal of Hematology · doi:10.1002/ajh.27470 · Cited by 119
Rafn, B. S., Christensen, J., Larsen, A. T. S., & Bloomquist, K. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01681 · Cited by 117
Sexual Function and Health-Related Quality of Life in Long-Term Rectal Cancer Survivors
Sun, V. C.-Y., GRANT, M. M., Wendel, C. S., McMullen, C. K., Bulkley, J. E., Herrinton, L. J., Hornbrook, M. C., & Krouse, R. S. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.05.005 · Cited by 116
Future of testicular germ cell tumor incidence in the United States: Forecast through 2026
Ghazarian, A. A., Kelly, S., Altekruse, S., Rosenberg, P. S., & McGlynn, K. (2017) · Cancer · doi:10.1002/cncr.30597 · Cited by 116
Testicular Germ Cell Tumors: A Review
Singla, N., Bagrodia, A., Baraban, E. G., Fankhauser, C. D., & Ged, Y. M. A. (2025) · JAMA · doi:10.1001/jama.2024.27122 · Cited by 114
Nogueira, L., Sahar, L., Efstathiou, J. A., Jemal, A., & Yabroff, K. R. (2019) · JAMA · doi:10.1001/jama.2019.7657 · Cited by 112
Self-citationEndocrine Therapy Nonadherence and Discontinuation in Black and White Women
Wheeler, S. B., Spencer, J. C., Pinheiro, L. C., Murphy, C. C., Earp, J. A., Carey, L., Olshan, A. F., Tse, C. K., Bell, M. B., Weinberger, M., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy136 · Cited by 107
Iveson, T. J., Sobrero, A. F., Yoshino, T., Souglakos, I., Ou, F., Meyers, J. P., Shi, Q., Grothey, A. F., Saunders, M. P., Labianca, R., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01330 · Cited by 105
Addressing Transportation Insecurity Among Patients With Cancer
Graboyes, E. M., Chaiyachati, K. H., Gall, J. S., Johnson, W., Krishnan, J. A., McManus, S. S., Thompson, L., Shulman, L. N., & Yabroff, K. R. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac134 · Cited by 105
Self-citationRivera, D. R. R., Ganz, P. A., Weyrich, M. S., Bandos, H., & Melnikow, J. A. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx140 · Cited by 103
Self-citationBRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis
Garutti, M., Bergnach, M., Polesel, J., Palmero, L., Pizzichetta, M. A., & Puglisi, F. (2022) · Cancers · doi:10.3390/cancers15010141 · Cited by 103
Factors Associated With Health-Related Quality of Life Among Cancer Survivors in the United States
Han, X., Williams, A. R., Jensen, R. E., Smith, T. G., & Yabroff, K. R. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa123 · Cited by 101
Self-citationOngoing ostomy self-care challenges of long-term rectal cancer survivors
Bulkley, J. E., McMullen, C. K., GRANT, M. M., Wendel, C. S., Hornbrook, M. C., & Krouse, R. S. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4268-0 · Cited by 99
Paramanandam, V. S., Dylke, E. S., Clark, G. M., Daptardar, A. A., Kulkarni, A. M., Nair, N. S., Badwe, R. A., & Kilbreath, S. L. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02567 · Cited by 96
Testicular Cancer Survivorship
Fung, C., Dinh, P. C., Fosså, S. D., & Travis, L. B. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.7369 · Cited by 95
Siembida, E. J., Loomans-Kropp, H. A., Trivedi, N. S., O’Mara, A. M., Sung, L., Tamí‐Maury, I., Freyer, D. R., & Roth, M. E. (2019) · Cancer · doi:10.1002/cncr.32675 · Cited by 95
Williams, A. M., Khan, C. P., Heckler, C. E., Barton, D. L., Ontko, M., Geer, J., Kleckner, A. S., Dakhil, S. R., Mitchell, J. W., Mustian, K. M., et al. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-06067-6 · Cited by 94
Financial Hardship and the Economic Effect of Childhood Cancer Survivorship
Nathan, P. C., Henderson, T. O., Kirchhoff, A. C., Park, E. R., & Yabroff, K. R. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.4431 · Cited by 90
Self-citationNekhlyudov, L., Campbell, G. B., Schmitz, K. H., Brooks, G. A., Kumar, A. J., Ganz, P. A., & Ah, D. M. V. (2021) · Cancer · doi:10.1002/cncr.33913 · Cited by 88
Self-citationHaddad, F., Sasaki, K., Issa, G. C., Garcia‐Manero, G., Ravandi, F., Kadia, T. M., Cortes, J. E., Konopleva, M. Y., Pemmaraju, N., Alvarado, Y., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26550 · Cited by 87
Nguyen, C., Lairson, D. R., Swartz, M. D., & Du, X. L. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2168 · Cited by 85
El‐Taji, O., Taktak, S., Jones, C. H., Brown, M. D., Clarke, N. W., & Sachdeva, A. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.1549 · Cited by 83
Rajan, K. K., Fairhurst, K., Birkbeck, B., Novintan, S., Wilson, R., Savović, J., Holcombe, C., & Potter, S. (2024) · BJS Open · doi:10.1093/bjsopen/zrae040 · Cited by 81
Yao, K. A., Winchester, D. J., Czechura, T., & Huo, D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2745-1 · Cited by 78
Postoperative Symptom Burden in Patients Undergoing Lung Cancer Surgery
Merlo, A. E., Carlson, R., Espey, J., Williams, B. M., Balakrishnan, P., Chen, S. L., Dawson, L., Johnson, D. J., Brickey, J. A., Pompili, C., et al. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.05.016 · Cited by 75
Fedewa, S. A., Lerro, C. C., Chase, D. M., & Ward, E. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.03.010 · Cited by 71
Is it time to reconsider the term “cancer survivor”?
Berry, L. L., Davis, S. W., Flynn, A. G., Landercasper, J., & Deming, K. A. (2019) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2018.1522411 · Cited by 66
Nogueira, L., Crane, T. E., Ortiz, A. P., D’Angelo, H. M., & Neta, G. I. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1234 · Cited by 61
Self-citationLi, R., Wang, K., Qu, C., Qi, W., Fang, T., Yue, W., & Tian, H. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-433 · Cited by 60
Peng, L., Wang, Y., Hong, Y. K., Ye, X., Shi, P., Zhang, J., & Zhao, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.21059 · Cited by 57
Cancer Survivorship Care Roles for Primary Care Physicians
Crabtree, B. F., Miller, W. L., Howard, J., Rubinstein, E. B., Tsui, J., Hudson, S. V., O’Malley, D. M., Ferrante, J. M., & Stange, K. C. (2020) · The Annals of Family Medicine · doi:10.1370/afm.2498 · Cited by 56
Antonelli, A., Allinovi, M., Cocci, A., Russo, G. I., Schiavina, R., Rocco, B. M. C., Pini, G., Celia, A., Antonio Galfano, A., Varca, V., et al. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.09.020 · Cited by 54
Gemine, R. E., Ghosal, R., Collier, G., Parry, D., Campbell, I., Davies, G., Davies, K., & Lewis, K. E. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.12.028 · Cited by 54
Dutcher, J. P., Flippot, R., Fallah, J., & Escudier, B. J. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280817 · Cited by 54
Current and coming challenges in the management of the survivorship population
Chow, E. J., Ness, K. K., Armstrong, G. T., Bhakta, N. H., Yeh, J. M., Bhatia, S., Landier, W., Constine, L. S., Hudson, M. M., & Nathan, P. C. (2020) · Seminars in Oncology · doi:10.1053/j.seminoncol.2020.02.007 · Cited by 53
Two decades of targeted therapies in acute myeloid leukemia
Cucchi, D. G. J., Polak, T. B., Ossenkoppele, G. J., Groot, C. A. U., Cloos, J. J., Zweegman, S., & Janssen, J. J. W. M. (2021) · Leukemia · doi:10.1038/s41375-021-01164-x · Cited by 53
Guo, X., Chen, S., Wang, X., & Liu, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1138483 · Cited by 53
Management of Long-Term Toxicity From Pelvic Radiation Therapy
Dalsania, R. M., Shah, K. P., Stotsky‐Himelfarb, E., Hoffe, S. E., & Willingham, F. F. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_323525 · Cited by 52
Advancing Health Equity in Cancer Survivorship
Smith, J. L., & Hall, I. J. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.08.008 · Cited by 51
Jazieh, A. R., Chan, S. L., Curigliano, G., Dickson, N. R., Eaton, V. J., García‐Foncillas, J., Gilmore, T. R., Horn, L., Kerr, D. J., Lee, J., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00423 · Cited by 51
Nogueira, L., May, F. P., Yabroff, K. R., & Siegel, R. L. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00539 · Cited by 51
Self-citationChida, K., Kotani, D., Masuishi, T., Kawakami, T., Kawamoto, Y., Kato, K., Fushiki, K., Sawada, K., Kumanishi, R., Shirasu, H., et al. (2021) · The Oncologist · doi:10.1002/onco.13870 · Cited by 50
Olsson, M., Enskär, K., Steineck, G., Wilderäng, U., & Jarfelt, M. (2018) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2017.0089 · Cited by 48
Barclay, M., Lyratzopoulos, G., Walter, F. M., Jefferies, S., Peake, M. D., & Rintoul, R. C. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212456 · Cited by 47
Cancer and COVID-19: US cancer incidence rates during the first year of the pandemic
Howlader, N., Bhattacharya, M., Scoppa, S., Miller, D. G., Noone, A., Negoita, S., Cronin, K. A., & Mariotto, A. B. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad205 · Cited by 47
Self-citationYabroff, K. R., Doran, J. F., Zhao, J., Chino, F. L., Shih, Y. T., Han, X., Zheng, Z., Bradley, C. J., & Bryant, M. F. (2024) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21837 · Cited by 47
Self-citationAssociation of Wildfire Exposure While Recovering From Lung Cancer Surgery With Overall Survival
Zhang, D., Xi, Y., Boffa, D. J., Liu, Y., & Nogueira, L. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.2144 · Cited by 45
Self-citationRoghmann, F., Becker, A., Trinh, Q., et al. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.221 · Cited by 44
State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation
Pathak, P., Chan, G. H. J., Deming, D. A., & Chee, C. E. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_438466 · Cited by 44
Hayes, B. D., Young, H. G., Atrchian, S., Vis‐Dunbar, M., Stork, M., Pandher, S., Samper, S., McCorquodale, S., Loader, A., & Voss, C. (2022) · Journal of Cancer Survivorship · doi:10.1007/s11764-022-01268-y · Cited by 43
Rigney, M., Rapsomaniki, E., Carter‐Harris, L., & King, J. C. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.09.011 · Cited by 38
Zhao, J., Reese, J. B., Han, X., & Yabroff, K. R. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7114 · Cited by 38
Self-citationLambertini, M., Blondeaux, E., Perrone, F., & Mastro, L. D. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.02242 · Cited by 37
Radioactive iodine and female fertility
Navarro, P., Rocher, S., Miró–Martínez, P., & Oltra–Crespo, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-07592-8 · Cited by 37
Pederzoli, F., Campbell, J. D., Matsui, H., Sopko, N. A., & Bivalacqua, T. J. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.11.003 · Cited by 36
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer
Washington, S. L., Neuhaus, J. M., Meng, M. V., & Porten, S. P. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1280 · Cited by 35
Bitterman, D. S., Bona, K. O., Laurie, F., Kao, P., Terezakis, S. A., London, W. B., & Haas-Kogan, D. A. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.2259 · Cited by 35
Lambertini, M., Arecco, L., Woodard, T. L., Messelt, A., & Rojas, K. E. (2023) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_390442 · Cited by 34
Beebe‐Dimmer, J., Ruterbusch, J. J., Cooney, K. A., Bolton, A., Schwartz, K., Schwartz, A. G., & Heath, E. I. (2019) · Cancer Medicine · doi:10.1002/cam4.2092 · Cited by 33
Racial Disparities in Resection of Early Stage Non–Small Cell Lung Cancer
Ezer, N., Mhango, G., Bagiella, E., Goodman, E., Flores, R. M., & Wisnivesky, J. P. (2019) · Medical Care · doi:10.1097/mlr.0000000000001280 · Cited by 32
Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer
Baskin, A. S., Wang, T., Bredbeck, B. C., Sinco, B. R., Berlin, N. L., & Dossett, L. A. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2020.12.057 · Cited by 32
Hammoud, R. A., Liu, Q., Dixon, S. B., Onerup, A., Mulrooney, D. A., Huang, I., Jefferies, J. L., Rhea, I. B., Ness, K. K., Ehrhardt, M. J., et al. (2024) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00157-8 · Cited by 32
Hao, S. B., Snyder, R. A., Irish, W. D., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003842 · Cited by 31
Schmitz, K. H., Demanelis, K., Crisafio, M. E., Kennedy, M. A., Schwartz, A. L., Campbell, A., Gorzelitz, J., Wood, K. C., Wilson, C. M., Scalise, R. L., et al. (2024) · Cancer · doi:10.1002/cncr.35515 · Cited by 30
Advances in the treatment of Hodgkin lymphoma: Current and future approaches
Ullah, F., Dima, D., Omar, N., Ogbue, O., & Ahmed, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1067289 · Cited by 29
Surveillance after resection for colorectal cancer
Brawarsky, P., Neville, B. A., Fitzmaurice, G. M., Earle, C. C., & Haas, J. S. (2012) · Cancer · doi:10.1002/cncr.27852 · Cited by 28
Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer
Marinaro, J. A., Zeymo, A., Egan, J. M., et al. (2020) · Urology · doi:10.1016/j.urology.2020.06.087 · Cited by 28
Trends in Active Surveillance for Men With Intermediate-Risk Prostate Cancer
Diven, M. A., Tshering, L., Ma, X., Hu, J. C., Barbieri, C. E., McClure, T., & Nagar, H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.29760 · Cited by 28
Zgardau, A., Ray, J. G., Baxter, N. N., Nagamuthu, C., Park, A. L., Gupta, S., & Nathan, P. C. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac005 · Cited by 27
Posttraumatic stress-related psychological functioning in adult survivors of childhood cancer
Allen, J. M., Willard, V. W., Klosky, J. L., Li, C., Srivastava, D. K., Robison, L. L., Hudson, M. M., & Phipps, S. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0660-x · Cited by 26
Luo, X., Li, J., Chen, M., Gong, J., Xu, Y., & Li, Q. (2021) · Psycho-Oncology · doi:10.1002/pon.5657 · Cited by 24
Hassan, A. M., Nogueira, L., Lin, Y.-L., Rogers, J. E., Nori‐Sarma, A., & Offodile, A. C. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.01951 · Cited by 24
Self-citationGolla, V., Lenis, A. T., Faiena, I., & Chamie, K. (2019) · PubMed · Cited by 23
Schoenbeck, K. L., Atallah, E. L., Lin, L., Weinfurt, K. P., Cortes, J. E., Deininger, M. W., Kota, V. K., Larson, R. A., Mauro, M. J., Oehler, V. G., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab184 · Cited by 22
Espinel, Z., Shultz, J. M., Aubry, V. P., Abraham, O. M., Fan, Q., Crane, T. E., Sahar, L., & Nogueira, L. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad139 · Cited by 22
Self-citationDisparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population
Corey, L., Coté, M. L., Ruterbusch, J. J., Vezina, A., & Winer, I. S. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.10.031 · Cited by 21
Cited by
Marzi, M., Ghasemian, A., Ghanbariasad, A., Nournia, E., & Zarenezhad, E. (2026) · RSC Advances · doi:10.1039/d5ra09799a
Metadata
- Authors
- Wagle, N. S., Nogueira, L., Devasia, T. P., Mariotto, A. B., Yabroff, K. R., Islami, F., Jemal, A., Alteri, R., Ganz, P. A., & Siegel, R. L.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2025-05-30
- Volume
- 75
- Issue
- 4
- Pages
- 308-340
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W4410893209
- Cited by
- 261
- References
- 223
- FWCI
- 91.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.